IP21-22: Five-Year Retreatment and Medication Restart Rates Following Benign Prostate Hyperplasia Treatments: A Nationwide Real-World Analysis Using Epic Cosmos
Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146B
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!